Ophthalmic Solution Articles & Analysis

1 articles found

Aramis Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial Evaluating A197 for the Treatment of Dry Eye Disease

” About A197-CS-201 The phase 2, multicenter, double-masked, randomized, vehicle-controlled, parallel-group clinical trial (NCT05238597) is designed to evaluate the safety and tolerability as well as explore the efficacy of two doses of A197 ophthalmic solution in approximately 200 patients with dry eye disease. ...

Feb. 28, 2022

ByVEO Ophthalmics, LLC

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you